{"entity":{"type":"insider","cik":"0001779160","url":"/insider/0001779160","json_url":"/insider/0001779160.json","name":"Wilkins H Jeffrey","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2021-06-14","last":"2021-12-14","span_basis":"filed_date"},"name_variants":[{"name":"Wilkins H Jeffrey","source":"filing","n_filings":2,"first_seen":"2021-06-14","last_seen":"2021-12-14"}],"transactions":[{"id":4442470,"accession":"0001879785-21-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001879785-21-000041","line_url":"/filing/0001879785-21-000041#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001779160","owner_name":"Wilkins H Jeffrey","owner_display_name":"Wilkins H Jeffrey","owner_url":"/insider/0001779160","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6371.0,"shares_display":"6,371","price_per_share":1.57,"price_display":"1.57","price_state":"stated","total_value":10002.47,"total_display":"10,002.47","total_whole":"10,002","shares_owned_after":33373.0,"shares_owned_after_display":"33,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-14","scope":"insider"},{"id":4472430,"accession":"0001192482-21-000498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-21-000498","line_url":"/filing/0001192482-21-000498#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Cerecor Inc.","issuer_ticker":"CERC","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001779160","owner_name":"Wilkins H Jeffrey","owner_display_name":"Wilkins H Jeffrey","owner_url":"/insider/0001779160","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":912.0,"shares_display":"912","price_per_share":2.28,"price_display":"2.28","price_state":"stated","total_value":2079.36,"total_display":"2,079.36","total_whole":"2,079","shares_owned_after":27002.0,"shares_owned_after_display":"27,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001534120","name":"Avalo Therapeutics, Inc.","url":"/issuer/0001534120","role":"Officer (Chief Medical Officer)","n_filings":2,"first_seen":"2021-06-14","last_seen":"2021-12-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001779160","retrieved_at":"2026-08-22T19:06:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}